Newsletter Archive

  1. 07.17.26 -- Does The FDA's Plausible Mechanism Pathway Revolutionize The Way All Risks Are Analyzed? 7/17/2026
    07/17/26 Pharmaceutical Online Newsletter
  2. 07.16.26 -- Human-Centric Models For Modern Drug Development 7/16/2026

    07/16/26 Pharmaceutical Online Newsletter

  3. 07.16.26 -- What Biopharma Often Overlooks In A Scheduled Shutdown 7/16/2026
    07/16/26 Pharmaceutical Online Newsletter
  4. 07.16.26 -- STREAM Edition: High-Volume GLP-1 Manufacturing: Challenges And Bottlenecks On A Global Scale 7/16/2026

    07/16/26 Pharmaceutical Online Newsletter

  5. 07.14.26 -- Practical Strategies for Contamination Control and EM Compliance 7/14/2026

    07/14/26 Pharmaceutical Online Newsletter

  6. 07.14.26 -- Achieving Annex 1 Compliance In Sterile Manufacturing, Part 2: Objective Measurement Tools 7/14/2026
    07/14/26 Pharmaceutical Online Newsletter
  7. 07.11.26 -- Pharmaceutical Online Newsletter - Best Of June 7/11/2026
    07/11/26 Pharmaceutical Online Newsletter
  8. 07.11.26 -- Facilities And Cleanrooms Product Showcase 7/11/2026
    07/11/26 Pharmaceutical Online Newsletter
  9. 07.10.26 -- [VIDEO] GLP-1 Manufacturing's New Bottlenecks At Multi-Ton Scale 7/10/2026
    07/10/26 Pharmaceutical Online Newsletter
  10. 07.09.26 -- Manufacturing Insights for Large Molecule Development 7/9/2026

    07/09/26 Pharmaceutical Online Newsletter